Manufacturing consultancy up 150% as life sciences prepare for a digital future
Increasing appetite for digitised manufacturing and using data to improve GMP manufacturing.
Zenith Technologies has seen a 150% rise in demand for its consultancy arm services. The company's consultancy has seen an increasing appetite for digitised manufacturing and using data to improve GMP manufacturing over the past 12 months.
The growth of the service in 2018 was driven by a need to aid customers in collecting, contextualising and finding insights in their stored data. These insights can then be used to make informed decisions on production processes and the supply chain.
Jaqueline Hora, Global Digital and Data Analytics Lead at Zenith Technologies said: “The life science industry has seen a remarkable trend towards innovation utilising data and technology effectively. Digital strategies, as well as manufacturing execution systems (MES) and automation, are in great demand as a result.
“For customers implementing these digital strategies, project decision support as well as process, technology and project execution knowledge, are essential to ensure success.
“Our Consultancy team supports customers that are considering new technology projects and assists in developing strategies, governance and standards to provide a framework for success.
“Whether it be justifying ROI, validating a customer’s strategy, process and methodology implementation expertise or help with technology selection, Zenith has been there to support its customer base.
“Zenith’s intimate understanding of manufacturing systems, extensive process knowledge and significant experience serving the life science sector has ensured that our customers have the insight needed to make the best decision.”
The increase is in part a direct result of the emergence of Industry 4.0 with data integrity, data analytics, the internet of things, and cloud strategies becoming a reality throughout the life science industry.
The team’s growth is projected to continue into 2019 as the life science industry increases its focus on digitisation and using data to improve GMP manufacturing practices.
In a recent survey of the industry, Zenith found nearly 60% of participants believe that Industry 4.0 will drive the most change in life science over the next 5 years, with 75% of those aiming to invest in people to take advantage of emerging technologies.
Related News
-
News Patients vs Pharma – who will the Inflation Reduction Act affect the most?
The Inflation Reduction Act brought in by the Biden administration in 2022 aims to give better and more equitable access to healthcare in the USA. However, pharma companies are now concerned about the other potential costs of such legislation. -
News CPHI Podcast Series: What does the changing US Pharma market mean for industry and patients alike?
In this week's episode of the CPHI Podcast Series Lucy Chard, Digital Editor for CPHI Online is joined by James Manser to discuss the political and market changes in the US pharma field. -
News CPHI Barcelona Annual Report illuminates industry trends for 2024
The CPHI Annual Survey comes into it’s 7th year to report on the predicted trends for 2024. Over 250 pharma executives were asked 35 questions, with their answers informing the industry landscape for the next year, spanning all major pharma marke... -
News Which 10 drugs are open to price negotiation with Medicare in the USA?
The Centres for Medicare & Medicaid Services, under the Biden administration in the USA, has released a list of the 10 drugs that will be open to price negotiations as part of the new legislation under the Inflation Reduction Act (IRA). -
News EU Medical Devices Regulation causes unintended disappearances of medical devices for children, doctors state
Doctor groups and associations have appealed to the EU to correct the EU Medical Devices Regulation law that may cause unintended shortages of essential drug and medical devices for children and rare disease patients. -
News 10 Major Drug Approvals So Far in 2023
Last year, 37 novel drugs were approved by the FDA, this was a high number for such a category, and covered many fields including oncology, demonstrating how promising further research is, and how it is only continuing to build. To date, there are alre... -
News Detecting Alzheimer's disease with a simple lateral flow test
A novel rapid diagnostic test for early-stage Alzheimer's disease has been developed using a biomarker binder from Aptamer Group along with technology from Neuro-Bio, the neurodegenerative disease experts. -
News CPHI Podcast Series: outsourcing and manufacturing trends
Listen to the CPHI Podcast Series this June to hear Gil Roth of the PBOA speak with Digital Editor Lucy Chard about the biggest trends and topics to watch in pharma outsourcing and manufacturing at the minute.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance